PTP4A3 and Miyoshi myopathy: Consistently, we found a dose-dependent reduction in STAT3 phosphorylation with the use of PRL-3 inhibitor I. Our data therefore support that PRL-3 expression can lead to a constitutively active STAT3 signal, thus rendering the IL-6-dependent MM cells less dependent on IL-6 for survival.